Ra Capital Management, L.P. Astria Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 5,043,756 shares of ATXS stock, worth $59.3 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
5,043,756Holding current value
$59.3 Million% of portfolio
0.69%Shares
4 transactions
Others Institutions Holding ATXS
# of Institutions
102Shares Held
49.4MCall Options Held
27.6KPut Options Held
29.7K-
Perceptive Advisors LLC New York, NY6.49MShares$76.2 Million1.71% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$42.4 Million3.6% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$41.8 Million6.42% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$41.3 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY3.25MShares$38.2 Million2.21% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $178M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...